Eli Lilly and Co Sustainability Reports
Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products worldwide. The company focuses on therapeutic areas including diabetes, obesity, oncology, immunology, and neuroscience.
Sector: Manufacturing
Country: United States
Exchange: New York Stock Exchange
LEI: FRDRIPF3EKNDJ2CQJL29
FIGI: BBG001S5STL8
32 reports from 2007 to 2025
